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Abstract 
Background: Sydnone is a heterocycle that exhibits remarkable pharmacological activities, including antimicro-
bial, anti-inflammatory, analgesic, antipyretic and antioxidant activities. Thiosemicarbazones are of compounds that 
contain the –NHCSNHN=C< linkage group and are considerable interest because they exhibit important chemical 
properties and potentially beneficial biological activities. Similarly, thiosemicarbazones having carbohydrate moieties 
also exhibit various significant biological activities.
Results: The compounds of 3-formyl-4-phenylsydnones were obtained by Vilsmeyer-Haack’s formylation reac-
tion and were transformed into thiosemicarbazones by condensation reaction with N-(2,3,4,6-tetra-O-acetyl-β-d-
glucopyranosyl)thiosemicarbazide. Reaction were performed in the presence glacial acetic acid as catalyst using 
microwave-assisted heating method. Reaction yields were 43‒85 %. The antimicrobial activities of these thiosemi-
carbazones were screened in vitro by using agar well diffusion and MIC methods. Among these thiosemicarbazones, 
compounds 4k, 4l, 4m and 4n were more active against all tested bacterial strains, especially against S. epidermidis, 
B. subtilis and E. coli. The MIC values in these cases are 0.156, 0.156 and 0.313 μg/mL, respectively. All compounds 
showed weak to moderate antifungal activity against C. albicans and A. niger than nystatin (MIC = 0.156‒0.625 μg/
mL vs. MIC = 0.078 μg/mL of nystatin), and thiosemicarbazones 4l, 4m and 4n exhibited significant activity with 
MIC = 0.156 μg/mL. These compounds also had good antifungal activity against F. oxysporum similarly to nystatin 
(MIC = 0.156 μg/mL). Among the tested compounds having halogen group 4k, 4l, 4m and 4n showed highest activ-
ity against three strains of fungal organisms.
Conclusions: In summary, we have developed a clean and efficient methodology for the synthesis of novel thio-
semicarbazone derivatives bearing sydnone ring and d-glucose moiety; the heterocyclic and monosaccharide system 
being connected via ‒NH‒C(=S)NH‒N=C< linker using molecular modification approach. The methodology could 
be further extended and used for the synthesis of other thiosemicarbazones of biological importance. 4-Formyl-3-ar-
ylsydnone N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones have been synthesized under microwave-
assisted heating conditions. Almost all obtained compounds showed remarkable activities against the tested microor-
ganisms. Among the tested compounds having halogen group 4k, 4l, 4m and 4n showed highest activity against all 
tested strains of bacterial and fungal organisms.
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Background
Sydnone is a mesoionic aromatic system, which could 
be described with some polar resonance structures [1]. 
Several compounds containing a sydnone ring exhibit 
remarkable pharmacological activities, including anti-
microbial, anti-inflammatory, analgesic, antipyretic and 
antioxidant activities [2–5].
Thiosemicarbazones are compounds that contain the –
NHCSNHN=C< linkage group. This class of compounds 
is of considerable interest because thiosemicarbazones 
exhibit the important chemical properties and potentially 
beneficial biological activities [6–9]. Some thiosemicar-
bazones of 3-aryl-4-formylsydnones were synthesized in 
good yields by the reactions of 3-aryl-4-formylsydnones 
with 4′-phenylthiosemicarbazide and thiosemicarbazide, 
respectively [3, 4]. On the other hand, some monosaccha-
ride thiosemicarbazides are of interested because these 
derivatives could be used as versatile intermediates for 
synthesis of various derivatives (especially heterocycles 
[10]) as well as be used for making complex formations of 
metallic ions [11, 12].
Thiosemicarbazones having carbohydrate moieties 
also exhibit various significant biological activities. In 
recent times, a number of thiosemicarbazones deriva-
tives containing monosaccharide moiety have not yet 
been synthesized more. In general, thiosemicarbazones 
derivatives containing monosaccharide moiety have 
showed remarkable anti-microorganism and antioxidant 
activity both in vivo and in vitro [13–15]. Some articles 
have been reported about the synthesis of substituted 
aromatic aldehyde/ketone N-(per-O-acetylated glyco-
pyranosyl)thiosemicarbazones in the past [10, 13–15]. 
These compounds have been synthesized by reaction of 
N-(per-O-acetylglycosyl)thiosemicarbazides with the 
corresponding carbonyl compounds [10, 13, 16–24], but 
the thiosemicarbazones containing both monosaccha-
ride and sydnone moieties have not been reported yet. 
Continuing the previous studies on the synthesis and the 
reactivity of N-(per-O-acetyl-d-glycopyranosyl)thiosemi-
carbazides [15, 24], we report in the present paper a study 
on the synthesis, spectral characterization, antibacterial 
and antifungal activity of a series of N-(tetra-O-acetyl-β-
d-glucopyranosyl)thiosemicarbazones having sydnone 
moiety by using microwave-assisted heating method [25].
Results and discussion
Chemistry
Required substituted 4-arylsydnones 1a–o [26, 27] and 
3-aryl-4-formylsydnone 2a–o [28, 29] were prepared 
with some modifications. 3-Arylsydnones were obtained 
in 43‒85  % yields. These sydnones are solid with yel-
low colour and high melting temperature. By Vilsmeier-
Haack’s reaction, starting from these sydnones we 
obtained the corresponding substituted 3-phenyl-4-for-
mylsydnones in 17‒50 % yield (Scheme 1). This reaction 
has been modified by Shih and Ke’s method [30].
Condensation reaction of substituted 3-phenyl-
4-formylsydnones  2a-o with N-(tetra-O-acetyl-β-d-
glucopyranosyl)thiosemicarbazide  3 was carried out on 
refluxing in the presence of glacial acetic acid as catalyst. 
These reactions were executed under microwave-assisted 
heating. All the microwave heating experiments were 
conducted under optimized reaction conditions of power 
and temperature in reflux-heating conditions that were 
investigated below (Scheme 2).
It’s known that peracetylated glucopyranosyl thio-
semicarbazones, in particular, and thiosemicarbazones 
containing other sugars, in general, were sometimes syn-
thesized in severe conditions, in the presence of acidic 
catalysts, such as hydrochloric or acetic acids in organic 
solvent, such as methanol, ethanol, propanol under 
conventional heating conditions [10, 13–24]. The reac-
tion time of these protocols are usually lengthy (2‒48 h). 
Therefore the search for methods of smooth conditions 
are always laid out. Initially, we prepared a typical pera-
cetylated (β-d-glucopyranosyl)thiosemicarbazone 4a 
from 4-formyl-3-phenylsydnone 2a (R=H) and thiosemi-
carbazide 3 under the usual conditions in our procedure 
for synthesis of these thiosemicarbazones (Scheme  2). 
This procedure used absolute ethanol as solvent, gla-
cial acetic acid as catalyst, and the reaction mixture was 
heated under conventional heating method or micro-
wave-assisted conditions. We have evaluated the irradia-
tion time and the effect of microwave power on reaction 
time and product yield for these reactions (Table 1).
In the process of synthesizing the compounds of 3-aryl-
4-formylsydnone N-(2,3,4,6-tetra-O-β-d-glucopyranosyl)
thiosemicarbazones 4a–o, the reaction times were moni-

























Scheme 1 Synthetic pathway for 3-aryl-4-formylsydnones 2a-n and 
3-cyclohexyl-4-formylsydnone 2o
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system ethyl acetate-toluene (2:1 v/v). In the case of con-
ventional heating method, product was obtained in yield 
of 50  % for 120  min under refluxing, while in the case 
of microwave-assisted heating method, this reaction 
afforded the yield of 71 % in only 25-min irradiation (The 
reaction time of 25 min was fixed in order to investigate 
the microwave power). We found that, initially, the pulses 
of 1  min of microwave irradiation at maximum power 
(800 W) were applied, but the yields were not reproduc-
ible, and it was difficult to maintain the heating of the 
reaction mixture. On the other hand, the pulses of 1 min 
allow to monitor when the reaction is complete by TLC, 
especially, in cases of the compound 4n which reaction 
time was 45 min.
The other high microwave power (from 600 to 300 W) 
were evaluated and the results were similar, except at 
450  W the yields were higher (71  %). This higher yield 
was also achieved at microwave power of 300  W (71  % 
yield). The influence of irradiation to isolated yield of 
4a was also examined. The results showed that the iso-
lated yields of 4a were 68, 71, 71.5 and 70  % with irra-
diation time of 20, 25, 27 and 30 min, respectively. This 
microwave power (300  W) was chosen as optimized 
condition, and was applied for synthesis of other thio-
semicarbazone 4b–o (Table  2). In the reaction process, 
products usually separated as colour solid after cooling to 
room temperature. The structure of 4-aryl-3-formylsyd-
none N-(tetra-O-acetyl-β-d-glucopyranosyl)thiosemicar-
bazones 4a–o were confirmed by spectroscopic methods.
We found that, in general, the electronic nature of the 
substituents R on the benzene ring of 4-arylsydnones 
does not affect significantly the reaction yields. How-
ever, the strong electron-withdrawing substituents such 
as NO2, Cl, Br, I slow down the reaction and prolong 
reaction time more than the electron-donating groups 
such as CH3, C2H5, OCH3, OC2H5 (Table  2). The yields 
of obtained thiosemicarbazones is quite high, from 63 
to 85 %, except the compound 4o, in this case the yield 
reached only 43 % after 45 min irradiation. As the result, 
compounds of 3-aryl-4-formylsydnone N-(2,3,4,6-tetra-
O-acetyl-β-d-glucopyranosyl)thiosemicarbazones (4a–o) 
have been synthesized with yields of 43‒85 %. Meanwhile, 
the conventional heating method only gave the yields of 
50‒60 % during prolonged reaction time from 100 min to 
150 min.
IR spectra show the characteristic absorption bands 
for two molecular components: sydnone and mono-
saccharide. IR spectral regions are 3476‒3343 and 
3334‒3164  cm‒1 (νNH thiosemicarbazone), 1777‒1746  cm−1 
(νC=O ester), 1624‒1599  cm‒1 (νCH=N), 1228–1222 and 
1056–1043  cm−1 (νCOC ester), 1092‒1090  cm‒1 (νC=S), 
some bands at 1549–1505  cm−1 (νC=C aromatic). The 
absorbance of carbonyl-lactone group of the sydnone 
ring was sometimes superposed partially by carbonyl-
ester group in the range 1777‒1746  cm‒1. The presence 
of the characteristic spectral regions for two moieties, 


































































Scheme 2 Synthetic pathway for 3-aryl- and 3-cyclohexyl-4-formylsydnone 4-(tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones 4a-o
Table 1 Different microwave powers used for  synthesis 
of 4a from 2a and 3 in absolute ethanol
a Catalyst: glacial acetic acid (2 mmol %) in absolute ethanol for 25 min
b Isolated yields






6 Conventional heating 50 (for 2 h)
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absorbance band in the range 1624‒1600 cm‒1 belong to 
azomethine bond in IR spectra indicated that the reac-
tion of 3-aryl-4-formylsydnones and N-(tetra-O-acetyl-β-
d-glucopyranosyl)thiosemicarbazide was occurred.
The 1H NMR spectra of these thiosemicarbazones 
showed the characteristic resonance signals of the pro-
tons present in the molecule, which are located in the 
region of δ  =  7.83–6.40  ppm for aromatic protons, 
δ  =  5.87–3.98  ppm for glucopyranose ring. Methyl 
groups in acetates had signals at δ  =  2.07–1.87  ppm. 
The interaction of protons on neighbour carbons in 
molecules could be shown in 1H–1H COSY spectrum of 
compound 4i (Fig. 1). The 13C NMR spectral data showed 
the carbon of the aromatic ring with the signals in the 
δ = 135.5–125.3 ppm, the carbon C-4‴ and C-5‴ of the 
sydnone ring has characteristic signal is in the range 
δ = 105.6–104.6 ppm and 165.9‒164.6 ppm, respectively. 
The carbon in the glucopyranose had chemical shifts at 
δ = 81.3–61.2 ppm. Carbon atoms in acetyl groups had 
signals at δ  =  21.5–20.1  ppm (for methyl group) and 
170.5–169.2 ppm (for carbonyl group).
From the structure of thiosemicarbazones 4a–o 
above we can confirm that the presence of sydnone 
round cannot be used 1H NMR spectrum, because the 
unique C–H bond of sydnone ring substituted by the 
other group. So the presence of the sydnone ring could 
be recognized by the presence of resonance signal lying 
in region at δ =  105.6–104.6  ppm. The HMBC spectral 
results of compound 4i showed the long-ranged interac-
tion that appeared in this spectrum (Fig. 2). Some typi-
cal ones are below: Carbon atom C-1′ (δ  =  80.4  ppm) 
interacts with proton H-2′ (δ = 4.55 ppm), carbon C-2′ 
(δ =  70.9  ppm) with protons H-1′ (δ =  5.86  ppm) and 
H-3′ (δ = 5.41 ppm), carbon C-3′ (δ = 72.1) with protons 
H-2′ and H-4′ (δ = 5.12 ppm), carbon C-4′ with protons 
H-3′ and H-6′b (δ = 4.00 ppm).
Antimicrobial screening
Antibacterial activities
Bacterium Staphylococcus epidermidis an cause a range 
of illnesses, from minor skin infections, such as pim-
ples, impetigo, boils (furuncles), cellulitis folliculitis, 
carbuncles, scalded skin syndrome, and abscesses, to 
life-threatening diseases such as pneumonia, meningi-
tis, osteomyelitis, endocarditis, toxic shock syndrome 
(TSS), bacteremia,… It is not a known human pathogen 
Table 2 Synthesis of  3-aryl- and  3-cyclohexyl-4-formylsydnone N-(tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarba-
zones (4a–o) under conventional and μ-wave heating
a Cyclohexyl group is attached directly to sydnone ring at position 4
Entry R Reaction time (min) Yield (%)
Conventional heating MW heating Conventional heating MW heating
4a H 100 25 50 71
4b 2-Me 120 28 55 75
4c 3-Me 130 30 55 73
4d 4-Me 130 30 56 76
4e 2,3-diMe 130 35 55 70
4f 2,4-diMe 130 35 50 68
4g 4-Et 120 28 60 83
4h 3-OMe 130 30 60 78
4i 4-OMe 130 30 60 81
4j 4-OEt 130 25 60 82
4k 4-F 130 30 55 65
4l 4-Br 150 35 55 63
4m 4-I 130 35 57 68
4n 2-Me-5-Cl 140 45 50 43
4o Cyclohexyla 130 30 60 85
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or disease causing agent. Bacillus subtilis produces the 
enzyme subtilisin, which has been reported to cause 
dermal allergic or hypersensitivity reactions in individu-
als repeatedly exposed to this enzyme. The bacteria Sal-
monella is commonly associated with food poisoning in 
countries all over the world, and the species that most 
people refer to when they talk about Salmonella is S. 
enterica. Salmonella infections can originate from house-
hold pets containing the bacteria, particularly reptiles, 
improperly prepared meats and seafood, or the surfaces 
of raw eggs, fruits, or vegetables that have not been ade-
quately disinfected. As their name suggests Salmonella 
enterica are involved in causing diseases of the intestines 
(enteric means pertaining to the intestine). The three 
main serovars of Salmonella enterica are Typhimurium, 
Enteritidis, and Typhi.
The ability of thiosemicarbazones 4a–o to inhibit 
the bacterial growth were screened in  vitro at 500  μg/
mL concentration against Staphylococcus epidermidis 
and Bacillus subtilis as Gram positive bacteria, Escheri-
chia coli and Pseudomonas aeroginosa as Gram negative 
bacteria using ciprofloxacin as standard antibacterial 
reference. The obtained results of testing antimicrobial 
activities of 3-aryl-4-formylsydnone N-(2,3,4,6-tetra-O-
β-d-glucopyranosyl)thiosemicarbazones 4a–o shows 
that some substances have significant bacterial inhibitory 
effects, but are less active than ciprofloxacin. The data 
from Table 3 revealed that almost all thiosemicarbazones 
have insignificant activity against Staphylococcus epider-
midis except compounds 4i, 4m and 4n that medium 
one. Almost all compounds are remarkable active to 
Bacillus subtilis except thiosemicarbazones 4b, 4c, 4g, 
and 4h. In general, thiosemicarbazone 4a–o are more 
active to Gram negative bacteria, namely Escherichia coli 
and Salmonella enterica (Table 3), except compounds 4j 
and 4o.
The MIC data in Table 4 indicated that almost all the 
compounds 4a–o showed good antibacterial activity, 
and some of them had the one similar to the standard 
drug ciprofloxacin, determined through the serial tube 
dilution method. Thiosemicarbazone 4k–n were more 
active against S. epidermidis than other ones with MIC 
Fig. 1 COSY spectrum of thiosemicarbazone 4i
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Fig. 2 HMBC spectrum of thiosemicarbazone 4i
Table 3 Antibacterial activity (paper disc diffusion method) 
of thiosemicarbazones 4a–o
Zone diameter of growth inhibition (mm) after 24 h: 50 μL of stock solution was 
applied in each hole of each paper disk, i.e. 25 μg/hole. Ciprofloxacin is used as a 
standard antibacterial reference. Control sample is 10 % DMSO solution in water
Entry Gram positive bacteria Gram negative 
bacteria
S. epidermidis B. subtilis E. coli S. enterica
4a 14 25 26 27
4b 13 16 25 26
4c 14 17 26 27
4d 14 27 28 31
4e 13 28 28 29
4f 14 27 29 30
4g 14 19 30 31
4h 13 20 29 30
4i 20 27 31 32
4j 14 28 14 13
4k 14 32 32 33
4l 14 34 34 33
4m 24 34 34 35
4n 19 32 31 30
4o 14 25 13 14
Ciprofloxacin 43 44 42 45
Control ‒ ‒ ‒ ‒
Table 4 Antibacterial activity (minimum inhibitory con-
centration, μg/mL) of thiosemicarbazones 4a–o
Entry Gram positive bacteria Gram negative 
bacteria
S. epidermidis B. subtilis E. coli S. enterica
4a 0.313 0.313 0.313 0.625
4b 0.313 0.313 0.625 0.313
4c 0.313 0.625 0.313 0.313
4d 0.313 0.313 0.313 0.625
4e 0.313 0.313 0.625 0.625
4f 0.313 0.625 0.313 0.625
4g 0.313 0.313 0.313 0.313
4h 0.313 0.313 0.313 0.625
4i 0.625 0.313 0.313 0.625
4j 0.313 0.313 0.313 0.625
4k 0.156 0.313 0.156 0.313
4l 0.156 0.156 0.156 0.313
4m 0.156 0.156 0.156 0.313
4n 0.156 0.156 0.156 0.313
4o 0.313 0.313 0.313 0.625
Ciprofloxacin 0.078 0.156 0.078 0.156
Control ‒ ‒ ‒ ‒
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values of 0.156  μg/mL. All compounds showed signifi-
cant activities for all bacterial strains used. Among these 
thiosemicarbazones, compounds 4k, 4l, 4m and 4n were 
more active against all tested bacterial strains, especially 
against S. epidermidis, B. subtilis and E. coli. The MIC 
values in these cases are 0.156, 0.156 and 0.313  μg/mL, 
respectively. Compounds 4k, 4l, 4m and 4n contain flu-
orine, bromine, iodine and chlorine group, respectively, 
whereas the remained thiosemicarbazones contains no 
halogen group in benzene ring. Overall most of the com-
pounds exhibit excellent antibacterial activity against the 
both tested Gram positive and Gram negative bacteria as 
compared to standard drug ciprofloxacin.
Antifungal activities
There are over 20 species of Candida yeasts that can 
cause infection in humans, the most common of which 
is Candida albicans. Candida yeasts normally live on the 
skin and mucous membranes without causing infection; 
however, overgrowth of these organisms can cause symp-
toms to develop. Symptoms of candidiasis vary depend-
ing on the area of the body that is infected. Fungus 
Fusarium oxysporum plays the role of a silent assassin—
the pathogenic strains of this fungus can be dormant for 
30 years before resuming virulence and infecting a plant. 
F. oxysporum is infamous for causing a condition called 
Fusarium wilt. Furthermore, F. oxysporum can be harm-
ful to both humans and animals, with its mycotoxins 
causing the diseases fungal keratitis, Onychomycosis, 
and Hyalohyphomycosis. Aspergillus niger is a fungus 
and one of the most common species of the genus Asper-
gillus. It causes a disease called black mould on certain 
fruits and vegetables such as grapes, apricots, onions, and 
peanuts, and is a common contaminant of food, but may 
also infect humans through inhalation of fungal spores.
The thiosemicarbazones 4a–o were screened against 
three fungal strains, namely Candida albicans, Fusarium 
oxysporum and Aspergillus niger. Tested concentration 
of these thiosemicarbazones is 500 μg/mL using nystatin 
as standard antifungal reference. Almost all tested com-
pounds have remarkable activities against these three 
fungal strains, but are less active than nystatin (Table 5). 
All compounds are significantly active to two first fungi, 
except substances 4b, 4c, 4g, 4h (against C. albicans) and 
4j, 4o (against F. oxysporum). Almost all thiosemicarba-
zones are resistant to fungus A. niger, except compound 
4j.
The MIC values listed in Table 6 showed that all thio-
semicarbazones had good antibacterial activity, but 
almost all compounds were equal or less active than the 
standard drug nystatin, determined through the serial 
tube dilution method. All compounds showed weak to 
moderate antifungal activity against C. albicans and 
A. niger than nystatin (MIC  =  0.156‒0.625  μg/mL vs. 
MIC  =  0.078  μg/mL of nystatin), and thiosemicarba-
zones 4l, 4m and 4n exhibited significant activity with 
MIC  =  0.156  μg/mL. These compounds also had good 
antifungal activity against F. oxysporum similarly to 
Table 5 Antifungal activity (paper disc diffusion method) 
of thiosemicarbazones 4a–o
Zone diameter of growth inhibition (mm) after 24 h: 50 μL of stock solution was 
applied in each hole of each paper disk, i.e. 25 μg/hole. Nystatin is used as a 
standard antifungal reference. Control sample is 10 % DMSO solution in water
Entry C. albicans F. oxysporum A. niger
4a 24 26 14
4b 16 27 13
4c 18 25 14
4d 26 26 23
4e 25 25 14
4f 25 25 13
4g 22 26 24
4h 21 25 22
4i 25 28 24
4j 27 14 26
4k 33 32 24
4l 34 35 14
4m 35 34 23
4n 31 30 24
4o 26 14 14
Nystatin 44 45 43
Control ‒ ‒ ‒
Table 6 Antifungal activity (minimum inhibitory concen-
tration, μg/mL) of thiosemicarbazones 4a–o
Entry C. albicans F. oxysporum A. niger
4a 0.625 0.313 0.625
4b 0.313 0.625 0.313
4c 0.313 0.156 0.313
4d 0.313 0.156 0.625
4e 0.625 0.625 0.625
4f 0.625 0.625 0.625
4g 0.313 0.313 0.156
4h 0.313 0.313 0.156
4i 0.313 0.313 0.625
4j 0.625 0.313 0.625
4k 0.313 0.156 0.156
4l 0.156 0.156 0.156
4m 0.156 0.156 0.156
4n 0.156 0.156 0.156
4o 0.313 0.313 0.625
Nystatin 0.078 0.078 0.156
Control – ‒ ‒
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nystatin (MIC = 0.156 μg/mL). Among the tested com-
pounds having halogen group 4k, 4l, 4m and 4n showed 
highest activity against three strains of fungal organisms.
Conclusions
The authors have developed an effective method for 
synthesis of 4-formyl-3-arylsydnone N-(2,3,4,6-tetra-O-
acetyl-β-d-glucopyranosyl)thiosemicarbazones under 
microwave-assisted conditions. These thiosemicarba-
zones have been obtained in good to excellent yields, 
except compound 4o, and fully characterized on the 
basis of their detailed spectral studies. Among the 
tested compounds having halogen group 4k, 4l, 4m and 
4n showed highest activity against all tested strains of 
bacterial and fungal organisms. This heating method is 
advantageous in having a smaller solvent volume and a 
shorter reaction time. We also believe that the proce-
dural simplicity, the efficiency and the easy accessibility 
of the reaction components give access to a wide array 
of heterocyclic frameworks bearing monosaccharide 
moiety. Almost all synthesized compounds had their 
antibacterial and antifungal activities evaluated and 
showed remarkable results. In summary, we have devel-
oped a clean and efficient methodology for the synthesis 
of novel thiosemicarbazone derivatives bearing sydnone 
ring and d-glucose moiety; the heterocyclic and mono-
saccharide system being connected via ‒NH‒C(=S)NH‒
N=C< linker using molecular modification approach. 
The methodology could be further extended and used 




All chemicals used for the synthesis of the desired com-
pounds were obtained from Merck chemicals. All other 
commercial reagents were used as received without 
additional purification. Melting points were measured 
on STUART SMP3 (BIBBY STERILIN, UK). The FTIS-
spectra was recorded on Impact 410 FT-IR Spectrom-
eter (Nicolet, USA), as KBr discs. The 1H NMR and 13C 
NMR spectra were recorded on an Avance Spectrometer 
AV500 (Bruker, Germany) at 500.13 and 125.77  MHz, 
respectively, using DMSO-d6 as solvent and TMS as an 
internal standard. Mass spectra were recorded on mass 
spectrometer LC–MS LTQ Orbitrap XL (ThermoScien-
tific, USA) or Agilent 6310 Ion Trap (Agilent Technolo-
gies, USA) in methanol, using ESI method. Thin-layer 
chromatography was performed on silica gel plates 60F254 
No. 5715 (Merck, Germany) with toluene: ethyl ace-
tate = 1:2 (by volume) as solvent system, and spots were 
visualized with UV light or iodine vapour. N-(Tetra-
O-acetyl-β-d-glucopyranosyl)thiosemicarbazide was 
synthesized using the method which described in Ref. 
[24] from corresponding isothiocyanate. Tetra-O-acetyl-
β-glucopyranosyl isothiocyanate were prepared by the 
reaction of tetra-O-acetyl-β-glucopyranosyl bromide 
with dry ammonium thiocyanate in absolute acetonitrile 
using tetrabutylammonium bromide as transfer cata-
lyst (modifying the Tashpulatov’s method [19, 20]). This 
bromide derivative was prepared from d-glucose using 
Lemieux’s procedure [31]. The obtained thiosemicarba-
zones were yellow or orange solids, insoluble in water, 
but easily soluble in ethanol, methanol, benzene, dichlo-
romethane, chloroform, ethyl acetate.
Synthesis of N‑(tetra‑O‑acetyl‑β‑d‑glucopyranosyl)
thiosemicarbazide (3)
To a solution of 2,3,4,6-tetra-O-acetyl-β-d-
glucopyranosyl isothiocyanate (3.89  g, 10  mmol) in 
25 mL of absolute ethanol, a solution of 85 % hydrazine 
hydrate (10 mmol, 1.2 ml) in 10 mL of absolute ethanol 
was added dropwise slowly with stirring in 30  min so 
that the reaction temperature is below 10  °C. The white 
precipitate appears immediately when several drops of 
hydrazine are added due to low solubility of this thio-
semicarbazide in ethanol. The temperature of solution 
was maintained between 10 and 12 °C. The mixture was 
continuously stirred at 20 °C for 30 min. The solid prod-
uct then was isolated by filtering with suction. The crude 
product was crystallized from 96 % ethanol to yield 3.75 g 
of white product 3. Yield 85 %, mp 156–158 °C; Ref. [19]: 
169‒171  °C. IR (KBr, cm‒1): ν 3322, 3129 (νNH), 1752 
(νC=O ester), 1355 (νC=S), 1242, 1043 (νCOC ester); 1H NMR 
(DMSO-d6) δ (ppm): 12.77 (s, 1H, NHb), 9.23 (s, 1H, NH), 
8.17 (s, 1H, NH), 4.58 (s, 2H, NH2), 5.80 (m, 1H, H-1), 
5.07 (t, J =  9.5  Hz, 1H, H-2), 5.34 (t, J =  9.75  Hz, 1H, 
H-3), 4.91 (t, J = 9.75 Hz, 1H, H-4), 4.14 (dd, J = 12.25, 
4.75  Hz, 1H, H-6a), 3.98‒3.93 (m, 2H, H-5 & H-6b), 
1.98–1.94 (s, 12H, 4  ×  CH3CO); 13C NMR (DMSO-
d6) δ (ppm): 182.1 (C=S), 169.9–169.2 (4  ×  COCH3), 
81.0 (C-1), 70.5 (C-2), 72.5 (C-3), 68.1 (C-4), 72.1 (C-5), 
61.8 (C-6), 20.4–20.2 (4  ×  CH3 CO); MS (+ESI): m/z 
(%) = 422.42 (45) [M+H]+, 462.28 (100) [M+K]+; calcd. 
for C15H23N3O9S = 421.12 Da.
General procedure for synthesis of 3‑aryl‑4‑formylsydnone 
N‑(tetra‑O‑acetyl‑β‑d‑glucopyranosyl)thiosemicarbazones 
(4a‑o)
To a solution of N-(tetra-O-acetyl-β-d-glucopyranosyl)
thiosemicarbazide 3 (2 mmol) in absolute ethanol (5 mL) 
was added substituted 3-aryl-4-formylsydnone 2a–o 
(2 mmol). Glacial acetic acid (2 mmol%) as catalyst was 
added dropwise with stirring. The obtained mixture 
was then irradiated in microwave oven for 25‒45  min 
(Tables 1, 2), cooled to room temperature, the separated 
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precipitate was filtered and recrystallized from 96 % eth-
anol to afford 4a–o.
3‑Phenyl‑4‑formylsydnone N‑(2,3,4,6‑tetra‑O‑acetyl‑β‑d‑gl
ucopyranosyl)thiosemicarbazone (4a)
Pale yellow crystals, mp 137‒138  °C (from 96  % eth-
anol), Rf =  0.57; [α]25D  +44.0 (c =  0.21, CHCl3); FTIR 
(KBr): ν/cm‒1 3343, 3122 (νNH), 1750 (νC=O ester and 
sydnone), 1600 (νCH=N), 1541 (νC=C), 1080 (νC=S), 
1235, 1037 (νCOC ester); 1H NMR (500  MHz, DMSO-
d6): δ 12.96 (s, 1H, NH-2), 7.83‒7.74 (m, 5H, H-2‴, 
H-3‴, H-4‴, H-5‴, H-6‴), 7.79 (s, 1H, CH=N), 7.05 (d, 
1H, J = 9.5 Hz, NH-4), 5.88 (t, 1H, J = 9.5 Hz, H-1ʹ), 
5.40 (t, 1H, J = 9.5 Hz, H-3ʹ), 5.02 (t, 1H, J = 9.75 Hz, 
H-4ʹ), 4.81 (t, 1H, J  =  9.5  Hz, H-2ʹ), 4.23 (dd, 1H, 
J  =  4.5, 12.25  Hz, H-6ʹa), 4.09 (ddd, 1H, J  =  1.75, 
3.75, 9.75  Hz, H-5ʹ), 3.99 (dd, 1H, J  =  1.0, 12.25  Hz, 
H-6ʹb), 2.06‒1.90 (s, 12H, 4  ×  CH3CO); 13C NMR 
(125  MHz, DMSO-d6): δ 177.7 (C=S), 170.5‒169.8 
(4 × CH3CO), 165.6 (C-5ʹʹ), 134.4 (C-1‴), 132.8 (C-3‴, 
C-4‴, C-5‴), 130.1 (CH  =  N), 126.0 (C-2‴, C-6‴), 
105.6 (C-4ʹʹ), 81.3 (C-1ʹ), 72.9 (C-3ʹ), 72.7 (C-5ʹ), 71.3 
(C-2ʹ), 68.3 (C-4ʹ), 61.2 (C-6ʹ), 21.0‒20.6 (4 × CH3CO); 
ESI–MS (+MS): m/z (%) 594.01 (M  +  H, 67), 407.12 
(25), 390.21 (10), 348.17 (20), 331.28 (8), 218.28 (5), 
190.37 (8), 176.39 (60), 132,56 (7), 117.41 (100), 




Pale yellow crystals, mp 119‒121 °C (from 96 % etha-
nol), Rf  =  0.60; [α]25D  +47.0 (c  =  0.22, CHCl3); FTIR 
(KBr): ν/cm‒1 3343 (νNH), 1749 (νC=O ester and syd-
none), 1600 (νCH=N), 1521 (νC=C), 1051 (νC=S), 1222, 
1056 (νCOC ester); 1H NMR (500  MHz, DMSO-
d6): δ 12.0 (s, 1H, NH-2), 7.72 (s, 1H, CH  =  N), 
7.71–7.68 (m, 2H, NH-4, H-3‴), 7.65‒7.60 (m, 1H, 
H-5‴), 7.60‒7.50 (m, 1H, H-4‴), 6.50‒6.40 (m, 1H, 
H-6‴), 5.85 (t, 1H, J  =  9.5  Hz, H-1ʹ), 5.40 (t, 1H, 
J  =  9.5  Hz, H-3ʹ), 5.05 (t, 1H, J  =  10.0  Hz, H-4ʹ), 
4.75 (t, 1H, J =  9.5  Hz, H-2ʹ), 4.26 (dd, 1H, J =  4.5, 
12.0  Hz, H-6ʹa), 4.10 (ddd, 1H, J =  2.0, 4.0, 10.0  Hz, 
H-5ʹ), 3.99 (d, 1H, J  =  12.0  Hz, H-6ʹb), 2.21 (s, 3H, 
2‴-CH3), 2.09‒1.90 (s, 12H, 4  ×  CH3CO); 13C NMR 
(125  MHz, DMSO-d6): δ 176.9 (C=S), 170.0‒169.3 
(4  ×  CH3CO), 165.5 (C-5ʹʹ), 133.6 (C-1‴), 132.3 
(C-3‴), 131.6 (C-5‴), 128.8 (C-4‴),128.6 (CH=N), 
127.7 (C-6‴), 126.2 (C-2‴), 105.0 (C-4ʹʹ), 80.7 (C-1ʹ), 
72.4 (C-5ʹ), 72.2 (C-3ʹ), 70.9 (C-2ʹ), 67.6 (C-4ʹ), 61.7 
(C-6ʹ), 20.5‒20.2 (4  ×  CH3CO), 20.1 (2‴-CH3); 




Yellow crystals, mp 148‒150  °C (from 96  % ethanol), 
Rf = 0.58; [α]25D  +59.1 (c = 0.27, CHCl3); FTIR (KBr): ν/
cm‒1 3525, 3164 (νNH), 1756 (νC=O ester and sydnone), 
1624 (νCH=N), 1532 (νC=C), 1084 (νC=S), 1237, 1041 (νCOC 
ester); 1H NMR (500  MHz, DMSO-d6): δ 11.98 (s, 1H, 
NH-2), 7.78 (s, 1H, CH=N), 7.63‒7.60 (m, 4H, H-2‴, 
H-4‴, H-5ʹʹ, H-6‴), 7.00 (d, 1H, J = 10.0 Hz, NH-4), 5.87 
(t, 1H, J =  9.5 Hz, H-1ʹ), 5.41 (t, 1H, J =  9.5 Hz, H-3ʹ), 
5.01 (t, 1H, J =  9.75  Hz, H-4ʹ), 4.72 (t, 1H, J =  9.5  Hz, 
H-2ʹ), 4.24 (dd, 1H, J =  4.5, 12.5  Hz, H-6ʹa), 4.10 (ddd, 
1H, J  =  2.0, 4.5, 10.0  Hz, H-5ʹ), 3.98 (dd, 1H, J  =  1.5, 
12.0 Hz, H-6ʹb), 2.46 (s, 3H, 3‴-CH3), 2.05‒1.90 (s, 12H, 
4 ×  CH3CO); 13C NMR (125  MHz, DMSO-d6): δ 177.2 
(C=S), 170.0‒169.3 (4  ×  CH3CO), 129.5 (CH=N), 80.7 
(C-1ʹ), 70.9 (C-2ʹ), 72.2 (C-3ʹ), 67.8 (C-4ʹ), 72.3 (C-5ʹ), 
61.7 (C-6ʹ), 104.9 (C-4ʹʹ), 165.1 (C-5ʹʹ), 140.2 (C-1‴), 
122.6 (C-2‴), 133.9 (C-3‴), 129.9 (C-4‴), 132.9 (C-5‴), 
125.6 (C-6‴), 20.7‒20.16 (4  ×  CH3CO), 20.7 (3‴-CH3); 




Yellow crystals, mp 149‒151  °C (from 96  % ethanol), 
Rf = 0.58; [α]25D  +52.3 (c = 0.25, CHCl3); FTIR (KBr): ν/
cm‒1 3329, 3215 (νNH), 1747 (νC=O ester and sydnone), 
1601 (νCH=N), 1510, 1537 (νC=C), 1083 (νC=S), 1226, 1043 
(νCOC ester); 1H NMR (500 MHz, DMSO-d6): δ 12.04 (s, 
1H, NH-2), 7.70 (s, 1H, CH = N), 7.75 (d, 2H, J = 9.0 Hz, 
H-3‴, H-5‴), 7.27 (d, 2H, J = 9.0 Hz, H-2‴, H-6‴), 6.73 
(d, 1H, J = 10.0 Hz, NH-4), 5.85 (t, 1H, J = 9.5 Hz, H-1ʹ), 
5.41 (t, 1H, J = 9.75 Hz, H-3ʹ), 5.12 (t, 1H, J = 9.75 Hz, 
H-4ʹ), 4.54 (t, 1H, J = 9.5 Hz, H-2ʹ), 4.27 (dd, 1H, J = 4.5, 
12.5 Hz, H-6ʹa), 4.11 (ddd, 1H, J = 2.0, 4.5, 10.0 Hz, H-5ʹ), 
3.99 (d, 1H, J =  12.5  Hz, H-6ʹb), 3.97 (s, 3H, 4‴–CH3), 
2.06‒1.87 (s, 12H, 4  ×  CH3CO); 13C NMR (125  MHz, 
DMSO-d6): δ 177.2 (C = S), 170.1‒169.2 (4 × CH3CO), 
165.9 (C-5ʹʹ), 161.5 (C-4‴), 129.9 (CH=N), 126.9 (C-3‴, 
C-5‴), 126.8 (C-1‴), 115.1 (C-2‴, C-6‴), 104.6 (C-4ʹʹ), 
80.4 (C-1ʹ), 72.3 (C-5ʹ), 72.1 (C-3ʹ), 70.8 (C-2ʹ), 67.5 (C-4ʹ), 
61.6 (C-6ʹ), 55.8 (4‴-CH3), 20.5‒20.1 (4  ×  CH3CO); 
ESI–MS (+MS): m/z (%) 608.00 (M+H, 55), 536.00 (10), 
412.11 (14), 407.15 (20), 390.19 (7), 348.13 (10), 321.36 
(25), 290.19 (8), 218.32 (5), 204, 138.30 (55), 139.18 (37), 




Pale yellow crystals, mp 138‒140 °C (from 96 % ethanol), 
Rf = 0.53; [α]25D  +47.0 (c = 0.23, CHCl3); FTIR (KBr): ν/
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cm‒1 1750 (νC=O ester and sydnone), 3338, 3124 (νNH), 
1610 (νCH=N), 1490, 1450 (νC=C), 1085 (νC=S), 1039, 1229 
(νCOC ester); 1H NMR (500 MHz, DMSO-d6): δ 11.97 (s, 
1H, NH-2), 7.70 (s, 1 H, CH = N), 7.39 (t, 2H, J = 7.0), 
H-4‴, H-5‴), 7.61 (s, 1H, H-6‴), 6.33 (dd, 1H, J = 9.5 Hz, 
NH-4), 5.81 (m, 1H, H-1ʹ), 5.36 (t, 2H, J = 9.5 Hz, H-3ʹ, 
H-4ʹ), 4.77 (m, 1H, H-2ʹ), 4.33 (t, 1H, J = 11.5 Hz, H-5ʹ), 
4.09 (d, 1H, J =  9.0 Hz, H-6ʹa, H-6ʹb), 2.45‒2.39 (s, 3H, 
2‴-CH3), 2.39‒2.09 (s, 12H, 4  ×  CH3CO), 1.89 (s, 3H, 
3‴-CH3); 13C NMR (125 MHz, DMSO-d6): δ 177.1 (C=S), 
170‒169.3 (4  ×  CH3CO), 165.6 (C-5ʹʹ), 139.0 (C-1‴), 
133.7 (C-2‴), 133.6 (C-3‴), 132.5 (C-4‴), 128.5 (CH=N), 
127.1 (C-6‴), 123.7 (C-5‴), 105.1 (C-4ʹʹ), 80.6 (C-1ʹ), 72.1 
(C-5ʹ), 71.7 (C-3ʹ), 71.4 (C-2ʹ), 67.6 (C-4ʹ), 61.6 (C-6ʹ), 
20.5‒20.1 (4  ×  CH3CO), 13.2 (2‴-CH3), 19.7 (3‴-CH3); 
ESI–MS (+MS): m/z (%) 622.03 (M+H, 87), 600.44 (5), 
590.29 (10), 556.47 (8), 473.51 (10), 407.29 (10), 390.41 
(6), 348.25 (12), 331.40 (6), 218.39 (12), 202.42 (40), 
132.44 (8), 122.33 (10), 117.36 (100), 102.59 (38), 74.43 
(25), 59.18 (53); calc. for C26H31N5O11S = 621.17 Da.
3‑(2,4‑Dimethylphenyl)‑4‑formylsydnone N‑(2,3,4,6‑tetra‑
O‑acetyl‑β‑d‑glucopyranosyl)thiosemicarbazone (4f)
Pale yellow crystals, mp 119‒121  °C (from 96  % etha-
nol), Rf  =  0.55; [α]25D  +46.0 (c  =  0.22, CHCl3); FTIR 
(KBr): ν/cm‒1 1753 (νC=O ester and sydnone), 3334, 3256 
(νNH), 1600 (νCH=N), 1530, 1450 (νC=C), 1080 (νC=S), 
1039, 1224 (νCOC ester); 1H NMR (500  MHz, DMSO-
d6): δ 12.04 (s, 1H, NH-2), 7.74  s, 1H, CH=N), 7.57 (t, 
1H, J  =  8.0  Hz, H-3‴), 7.42 (s, 1H, H-6‴), 7.35 (t, 1H, 
J = 8.0 Hz, H-5‴), 6.57 d; 1H, J = 10.0 Hz, NH-4), 5.89 
(m, 1H, H-1ʹ), 5.42 (m, 1H, H-3ʹ), 5.05 (s, 1H, H-4ʹ), 4.62 
(s, 1H, H-2ʹ), 4.21 (m, 1H, H-5ʹ), 4.15 d; 1H, J = 10.0 Hz, 
H-6ʹa), 3.99 d; 1H, J  =  5.75  Hz, H-6ʹb), 2.01‒1.90 (s, 
12 H, 4  ×  CH3CO), 2.52 (s, 3H (2‴–CH3), 2.12 (s, 3H 
(4‴–CH3); 13C NMR (125  MHz, DMSO-d6): δ 177.2 
(C=S), 169.9‒169.2 (4  ×  CH3CO), 165.6 (C-5ʹʹ), 142.0 
(C-1‴), 133.4 (C-4‴), 131.9 (C-2‴), 131.2 (C-5‴), 129.1 
(CH=N), 127.9 (C-3‴), 126.0 (C-6‴), 104.9 (C-4ʹʹ), 80.6 
(C-1ʹ), 72.5 (C-5ʹ), 70.9 (C-3ʹ), 67.8 (C-2ʹ), 65.0 (C-6ʹ), 
61.6 (C-4ʹ), 20.7‒20.1 (4 × CH3CO), 21.0 (4‴-CH3), 16.1 
(2‴-CH3); ESI–MS (+MS): m/z (%) 622.07 (M + H, 100), 
607.11 (10), 331.29 (6), 315.32 (20), 277.08 (5), 247.60 
(50), 219.29 (13), 189.51 (14), 161.50 (6), 132.50 (15), 




Pale yellow crystals, mp 138‒140 °C (from 96 % ethanol), 
Rf = 0.58; [α]25D  +59.0 (c = 0.27, CHCl3); FTIR (KBr): ν/
cm‒1 3310, 3228 (νNH), 1777 (νC=O ester and sydnone), 
1600 (νCH=N), 1551, 1518 (νC=C), 1084 (νC=S), 1228, 1043 
(νCOC ester); 1H NMR (500 MHz, DMSO-d6): δ 12.01 (s, 
1H, NH-2), 7.81 (s, 1H, CH = N), 7.74 (d, 2H, J = 8.25 Hz, 
H-3‴, H-5‴), 7.58 (d, 2H, J = 8.25 Hz, H-2‴, H-6‴), 7.08 
(d, 1H, J = 10.0 Hz, NH-4), 5.90 (t, 1H, J = 9.5 Hz, H-1ʹ), 
5.44 (t, 1H, J  =  9.5  Hz, H-3ʹ), 5.00 (t, 1H, J  =  9.5  Hz, 
H-4ʹ), 4.73 (t, 1H, J = 9.5 Hz, H-2ʹ), 4.19 (dd, 1H, J = 4.5, 
12.5  Hz, H-6ʹa), 4.10 (ddd, 1H, J  =  2.0, 4.5, 10.0  Hz, 
H-5ʹ), 3.99 (dd, 1H, J = 1.5, 12.5 Hz, H-6ʹb), 2.85 (q, 2H, 
J = 7.5 Hz, 4‴-CH2CH3), 2.04‒1.91 (s, 12H, 4 × CH3CO), 
1.30 (t, 3H, J = 7.5 Hz, 4‴-CH2CH3); 13C NMR (125 MHz, 
DMSO-d6): δ 177.3 (C=S), 170.0‒169.3 (4  ×  CH3CO), 
165.2 (C-5ʹʹ), 148.5 (C-1‴), 131.6 (C-4‴), 129.9 (CH=N), 
129.1 (C-3‴, C-5‴), 125.4 (C-2‴, C-6‴), 104.8 (C-4ʹʹ), 80.7 
(C-1ʹ), 72.3 (C-5ʹ), 72.1 (C-3ʹ), 70.9 (C-2ʹ), 67.7 (C-4ʹ), 61.4 
(C-6ʹ), 28.0 (4‴-CH2CH3), 20.6‒20.2 (4 × CH3CO), 15.0 




Yellow crystals, mp 139‒141  °C (from 96  % ethanol), 
Rf = 0.60; [α]25D  +53.2 (c = 0.24, CHCl3); FTIR (KBr): ν/
cm‒1 3476, 3334 (νNH), 1756 (νC=O ester and sydnone), 
1609 (νCH=N), 1528 (νC=C), 1093 (νC=S), 1228, 1040 
(νCOC ester); 1H NMR (500 MHz, DMSO-d6): δ 11.97 (s, 
1H, NH-2), 7.81 (s, 1H, CH=N), 7.64 (t, 1H, J = 7.5 Hz, 
H-5‴), 7.47 (t, 1H, J = 2.0 Hz, H-2‴), 7.38 (dd, 1H, J = 1.0, 
7.5 Hz, H-4‴), 7.34 (dd, 1H, J = 2.0, 7.5 Hz, H-6‴), 7.18 
(d, 1H, J = 9.5 Hz, NH-4), 5.88 (t, 1H, J = 9.5 Hz, H-1ʹ), 
5.42 (t, 1H, J  =  9.5  Hz, H-3ʹ), 5.00 (t, 1H, J  =  9.5  Hz, 
H-4ʹ), 4.80 (t, 1H, J = 9.5 Hz, H-2ʹ), 4.21 (dd, 1H, J = 5.0, 
12.25  Hz, H-6ʹa), 4.10 (ddd, 1H, J  =  2.0, 4.5, 10.0  Hz, 
H-5ʹ), 3.99 (dd, 1H, J  =  1.5, 12.25  Hz, H-6ʹb), 3.86 (s, 
3H, 3‴-OCH3), 2.05‒1.90 (s, 12H, 4  ×  CH3CO); 13C 
NMR (125 MHz, DMSO-d6): δ 177.2 (C=S), 170.1‒169.3 
(4 ×  CH3CO), 164.8 (C-5ʹʹ), 160.0 (C-3‴), 134.8 (C-1‴), 
131.0 (C-5‴), 129.7 (CH = N), 118.4 (C-6‴), 117.5 (C-4‴), 
111.0 (C-2‴), 105.1 (C-4ʹʹ), 80.8 (C-1ʹ), 72.3 (C-5ʹ), 72.2 
(C-3ʹ), 71.0 (C-2ʹ), 67.9 (C-4ʹ), 61.8 (C-6ʹ), 55.8 (3‴-
OCH3), 20.5‒20.2 (4 × CH3CO); ESI–MS (‒MS): m/z (%) 
622.3 (M‒H, 100); calc. for C25H29N5O12S = 623.15 Da.
3‑(4‑Methoxyphenyl)‑4‑formylsydnone N‑(2,3,4,6‑tetra‑O‑a
cetyl‑β‑d‑glucopyranosyl)thiosemicarbazone (4i)
Light yellow crystals, mp 160‒162 °C (from 96 % ethanol), 
Rf = 0.58; [α]25D  +65.0 (c = 0.26, CHCl3); FTIR (KBr): ν/
cm‒1 3344, 3260 (νNH), 1746 (νC=O ester and sydnone), 
1599 (νCH=N), 1549, 1505 (νC=C), 1093 (νC=S), 1223, 1043 
(νCOC ester); 1H NMR (500 MHz, DMSO-d6): δ 12.02 (s, 
1H, NH-2), 7.77 (s, 1H, CH=N), 7.74 (d, 2H, J = 8.75 Hz, 
H-3‴, H-5‴), 7.27 (d, 2H, J = 8.75 Hz, H-2‴, H-6‴), 6.75 
(d, 1H, J = 10.0 Hz, NH-4), 5.86 (t, 1H, J = 9.5 Hz, H-1ʹ), 
5.41 (t, 1H, J =  9.5  Hz, H-3ʹ), 5.12 (t, 1H, J =  9.75  Hz, 
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H-4ʹ), 4.55 (t, 1H, J = 9.5 Hz, H-2ʹ), 4.27 (dd, 1H, J = 4.0, 
12.25  Hz, H-6ʹa), 4.12‒4.10 (m, 1H, H-5ʹ), 4.00 (d, 1H, 
J =  12.25  Hz, H-6ʹb), 3.97 (s, 3H, 4‴-OCH3), 2.06‒1.78 
(s, 12H, 4 × CH3CO); 13C NMR (125 MHz, DMSO-d6): 
δ 177.2 (C=S), 170.1‒169.3 (4 × CH3CO), 165.9 (C-5ʹʹ), 
161.5 (C-4‴), 129.2 (CH=N), 126.9 (C-1‴), 127.0 (C-3‴, 
C-5‴), 115.1 (C-2‴, C-6‴), 104.6 (C-4ʹʹ), 80.4 (C-1ʹ), 72.3 
(C-5ʹ), 72.1 (C-3ʹ), 70.9 (C-2ʹ), 67.5 (C-4ʹ), 61.6 (C-6ʹ), 55.8 
(4‴-OCH3), 20.5‒20.1 (4  ×  CH3CO); ESI–MS (+MS): 
m/z(%) 624.01 (M  +  H, 100), 556.02 (7), 407.11 (15), 
391.21 (5), 348.17 (8), 331.25 (5), 204.21 (75), 124.22 (8), 




Light yellow crystals, mp 159–161  °C (from 96  % etha-
nol), Rf = 0.60; [α]25D  +54.0 (c = 0.22, CHCl3); FTIR (KBr): 
ν/cm‒1 3324, 3202 (νNH), 1737 (νC=O ester), 1601 (νC=N), 
1548, 1490 (νC=C), 1085 (νC=S), 1234, 1042 (νCOC ester); 
1H NMR (500  MHz, DMSO-d6): δ 12.04 (s, 1H, NH-2), 
7.78 (s, 1H, CH=N), 7.73 (d, 2H, J  =  8.75  Hz, H-3‴, 
H-5‴), 7.24 (d, 2H, J = 8.75 Hz, H-2‴, H-6‴), 6.75 (d, 1H, 
J = 10.0 Hz, NH-4), 5.88 (t, 1H, J = 9.5 Hz, H-1ʹ), 5.42 (t, 
1H, J = 9.5 Hz, H-3ʹ), 5.06 (t, 1H, J = 9.5 Hz, H-4ʹ), 4.60 
(t, 1H, J = 9.5 Hz, H-2ʹ), 4.26‒4.18 (m, 1H, H-6ʹa), 4.22 (q, 
2H, J = 7.5 Hz, 4‴-OCH2CH3), 4.10‒4.07 (m, 1H, H-5ʹ), 
3.99 (d, 1H, J = 12.5 Hz, H-6ʹb), 3.97 (t, 3H, J = 7.5 Hz, 
4‴-OCH2CH3), 2.07‒1.87 (s, 12H, 4  ×  CH3CO); 13C 
NMR (125 MHz, DMSO-d6): δ 177.3 (C=S), 170.1‒169.2 
(4  ×  CH3CO), 165.9 (C-5ʹʹ), 161.5 (C-4‴), 129.3 
(CH = N), 126.9 (C-3‴, C-5‴), 126.6 (C-1‴), 115.4 (C-2‴, 
C-6‴), 104.6 (C-4ʹʹ), 80.5 (C-1ʹ), 72.4 (C-3ʹ), 72.2 (C-5ʹ), 
70.7 (C-2ʹ), 67.7 (C-4ʹ), 64.1 (4‴-OCH2CH3), 61.6 (C-6ʹ), 
20.5‒20.2 (4  ×  CH3CO), 14.2 (4‴-OCH2CH3); ESI–MS 
(+MS): m/z(%) 638.00 (M + H, 60), 432.13 (7), 390.19 (8), 
348.11 (10), 331.20 (6), 234.30 (5), 218.29 (45), 190.29 (5), 
138.29 (10), 117.27 (100), 102.45 (62), 76.57 (13), 74.45 




Light yellow crystals, mp 176‒178  °C (from 96  % etha-
nol), Rf  =  0.55; [α]25D  +47.2 (c  =  0.24, CHCl3); FTIR 
(KBr): ν/cm‒1 1744 (νC=O ester and sydnone), 3329, 3186 
(νNH), 1597 (νCH=N), 1518, 1550 (νC=C), 1090 (νC=S), 
1056, 1229 (νCOC ester); 1H NMR (500 MHz, DMSO-d6): 
δ 12.00 (s, 1H, NH-2), 7.94‒7.91 (m, 2H, H-3‴,H-5‴), 
7.77 (s, 1H, CH=N), 7.58 (t, 2H, J  =  8.75  Hz, H-2‴, 
H-6‴), 6.74 (d, 1H, J  =  10.0  Hz, NH-4), 5.87 (t, 1H, 
J =  9.75  Hz, H-1ʹ), 5.44 (t, 1H, J =  9.75  Hz, H-3ʹ), 5.01 
(t, 1H, J  =  9.75  Hz, H-4ʹ), 4.69 (t, 1H, J  =  9.75  Hz, 
H-2ʹ), 4.22 (dd, 1H, J  =  9.0;9.0  Hz, H-5ʹ), 4.10 (m, 1H, 
H-6ʹa), 4.07‒4.00 (m, 1H, H-6ʹb), 2.05‒1.89 (s, 12H, 
4 ×  CH3CO); 13C NMR (125  MHz, DMSO-d6): δ 177.0 
(C=S), 170.7‒169.4 (4  ×  CH3CO), 167.2 (C-5ʹʹ), 165.9 
(C-4‴), 163.8 (CH=N), 144.1 (C-1‴), 129.9 (C-2‴), 127.6 
(C-6‴), 121.8 (C-3‴), 117.0 (C-5‴), 101.3 (C-4ʹʹ), 84.0 
(C-1ʹ), 83.9 (C-2ʹ), 73.8 (C-5ʹ), 72.5 (C-3ʹ), 70.4 (C-4ʹ), 61.4 
(C-6ʹ), 20.6‒20.5 (4 × CH3CO); ESI–MS (+MS): m/z (%) 
612.00 (M + H, 100), 580.18 (14), 503.97 (6), 452.18 (5), 
391.57 (35), 353.79 (8), 331.25 (8), 296.06 (12), 287.06 
(20), 272.29 (25), 246.83 (30), 229.10 (10), 202.44 (25), 
189.21 (27), 173.56 (45), 164.51 (14), 144.43 (10), 117.24 




Dark yellow crystals, mp 157‒159 °C (from 96 % ethanol), 
Rf = 0.53; [α]25D  +57.3 (c = 0.26, CHCl3); FTIR (KBr): ν/
cm‒1 1746 (νC=O ester and sydnone), 3083, 3289 (νNH), 
1610 (νCH=N), 1478, 1520 (νC=C), 1041 (νC=S), 1036, 1222 
(νCOC ester); 1H NMR (500  MHz, DMSO-d6): δ 11.98 
(s, 1H, NH-2), 8.05 (d, 2H, J  =  9.0  Hz, H-3‴, H-45ʹʹ), 
7.96 (s, 1H, CH  =  N), 7.90 (d, 2H, J  =  8.5  Hz, H-2‴, 
H-6‴), 6.75 (d, 1H, J  =  10.0  Hz, NH-4), 5.88 (t, 1H, 
J = 9.5 Hz, H-1ʹ), 5.48 (t, 1H, J = 9.5 Hz, H-3ʹ), 5.26 (t, 
1H, J = 9.75 Hz, H-4ʹ), 4.68 (t, 1H, J = 9.5 Hz, H-2ʹ), 4.23 
(dd, 1H, J = 9.5;8.0 Hz, H-5ʹ), 4.10 (d, 1H, J = 10.0 Hz, 
H-6ʹa), 4.01 (d, 1H, J  =  12.0  Hz, H-6ʹb), 2.08‒1.89 (s, 
12H, 4  ×  CH3CO); 13C NMR (125  MHz, DMSO-d6): δ 
177.4 (C=S), 170.5‒169.8 (4  ×  CH3CO), 156.2 (C-5ʹʹ), 
136.4 (C-1‴), 133.0 (C-3‴, C-5‴), 128.5 (CH = N), 123.3 
(C-2‴,C-6‴), 121.7 (C-4‴), 104.5 (C-4ʹʹ), 81.1 (C-1ʹ), 
71.3 (C-2ʹ), 72.9 (C-5ʹ), 72.3 (C-3ʹ), 68.3 (C-4ʹ), 62.2 
(C-6ʹ), 21.1‒20.6 (4  ×  CH3CO); ESI–MS (+MS): calc. 
for C24H2679BrN5O11S/C24H2681BrN5O11S  =  671.05/673.05 
Da; m/z (%) 671.13 (100)/673.15 (90) (M+), 642.01 (5), 




Dark yellow crystals, mp 128‒130 °C (from 96 % ethanol), 
Rf = 0.51; [α]25D  +55.0 (c = 0.20, CHCl3); FTIR (KBr): ν/
cm‒1 1750 (νC=O ester and sydnone), 2944, 3355 (νNH), 
1521 (νCH=N), 1456, 1521 (νC=C), 1045 (νC=S), 1045, 1226 
(νCOC ester); 1H NMR (500 MHz, DMSO-d6): δ 11.99 (s, 
1H, NH-2), 8.12 (d, 2H, J = 9.0 Hz, H-3‴, H-5‴), 7.80 (s, 
1H, CH = N), 7.64 (d, 2H, J = 8.5 Hz, H-2‴, H-6‴), 7.06 
(d, 1H, J = 10.0 Hz, NH-4), 5.91 (t, 1H, 9.5 Hz, H-1ʹ), 5.46 
(t, 1H, J = 9.75 Hz, H-3ʹ), 5.21 (t, 1H, J = 9.75 Hz, H-4ʹ), 
4.81 (t, 1H, J = 9.5 Hz, H-2ʹ), 4.20 (dd, 1H, J = 9.5;9.0 Hz, 
H-5ʹ), 4.11‒4.07 (m, 1H, H-6ʹa), 4.00 (dd, 1H J  =  4.0, 
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3.0  Hz, H-6ʹb), 2.06‒1.90 (s, 12H, 4  ×  CH3CO); 13C 
NMR (125 MHz, DMSO-d6): δ 177.3 (C=S), 170.0‒169.2 
(4  ×  CH3CO), 165.1 (C-5ʹʹ), 138.8 (C-1‴), 132.5 (C-3‴, 
C-5‴), 129.8 (CH=N), 127.4 (C-2‴, C-6‴), 119.3 (C-4‴), 
104.9 (C-4ʹʹ), 80.7 (C-1ʹ), 72.5 (C-5ʹ), 72.0 (C-3ʹ), 70.7 
(C-2ʹ), 68.0 (C-4ʹ), 61.7 (C-6ʹ), 20.6‒20.1 (4  ×  CH3CO); 




Dark yellow crystals, mp 122‒123 °C (from 96 % ethanol), 
Rf = 0.53; [α]25D  +43.2 (c = 0.22, CHCl3); FTIR (KBr): ν/
cm‒1 1754 (νC=O ester and sydnone), 3341, 3249 (νNH), 
1600 (νCH=N), 1526, 1450 (νC=C), 1080 (νC=S), 1040, 1227 
(νCOC ester); 1H NMR (500  MHz, DMSO-d6): δ 12.20 
(s, 1H, Hz, NH-2), 8.03 (d, 1H, J =  9.0 Hz, NH-4), 7.56 
(s, 1H, CH = N), 7.70‒7.47 (m, 3H, H-3‴, H-4‴, H-6‴), 
7.70‒7.47 (m, 2H, H-5‴, H-6‴), 5.97‒5.90 (m, 1H, H-1ʹ), 
5.29 (t, 1H, J = 9.75 Hz, H-3ʹ), 5.12 (t, 1H, J = 9.75 Hz, 
H-4ʹ), 5.08‒5.02 (m, 1H, H-2ʹ), 4.30 (dd, 1H, J  =  12.5, 
4.5  Hz, H-5ʹ), 4.10-4.07 (m, 1H, H-6ʹb), 3.87 (s, 3H, 
2‴-CH3), 3.84‒3.80 (m, 1H, H-6ʹa), 2.21–1.96 (s, 12H, 
4 ×  CH3CO); 13C NMR (125  MHz, DMSO-d6): δ 179.6 
(C =  S), 170.9‒169.6 (4 ×  CH3CO), 166.4 (C-5ʹʹ), 139.8 
(C-1‴), 131.9 (C-2‴), 132.4 (C-3‴), 126.4 (C-4‴), 132.9 
(C-5‴), 129.9 (CH = N), 127.3 (C-6‴), 104.3 (C-4ʹʹ), 82.1 
(C-1ʹ), 82.0 (C-2ʹ), 74.0 (C-5ʹ), 70.0 (C-3ʹ), 68.5 (C-4ʹ), 
62.0 (C-6ʹ), 20.8‒20.4 (4 × CH3CO), 16.6 (2ʹʹ-CH3); ESI–
MS (+MS): m/z (%) 642.02/644.03 (M +  H/M +  H+2, 
65/25), 619.15 (14), 605.51 (6), 550.78 (10), 5232.91 (15), 
474.38 (10), 462.39 (20), 448.45 (10), 430.52 (14), 414.45 
(10), 374.37 (6), 335.48 (12), 296.77 (10), 267.57 (40), 
240.37 (10), 139.54 (35), 117.58 (100), 102.52 (87), 81.39 




Dark yellow crystals, mp 126‒128 °C (from 96 % ethanol), 
Rf = 0.61; [α]25D  +44.0 (c = 0.21, CHCl3); FTIR (KBr): ν/
cm‒1 1756 (νC=O ester and sydnone), 3271, 2950 (νNH), 
1596 (νCH=N), 1530–1378 (νC=C), 1043 (νC=S), 1043, 1223 
(νCOC ester); 1H NMR (500 MHz, DMSO-d6): δ 12.07 (s, 
1H Hz, NH-2), 8.21 (d, 1H, J =  9.5  Hz, NH-4), 7.86 (s, 
1H, CH=N), 5.97 (t, 1H, J =  9.5  Hz, H-1ʹ), 5.44 (t, 1H, 
J = 9.75 Hz, H-3ʹ), 5.29 (t, 1H, J = 10.5 Hz, H-1‴), 5.10 
(t, 1H, J =  9.5  Hz, H-4ʹ), 4.93 (t, 1H, J =  9.75  HzH-2ʹ), 
4.19 (dd, 1H, J  =  2.0; 12.5  Hz, H-5ʹ), 4.11 (dd, 1H, 
J  =  4.5, 12.5 Hz, H-6ʹa), 3.97 (d, 1H, J  =  12.0  Hz, 
H-6ʹb), 2.20‒2.18 (m, 2H, 2 × H-3‴), 1.81‒1.74 (m, 2H, 
2 ×  H-4‴), 1.71‒1.63 (m, 2H, 2 ×  H-5‴), 1.54‒1.52 (m, 
2H, 2 × H-6‴), 1.29‒1.23 (m, 2H, 2 × H-2‴), 2.00‒1.95 
(s, 12H, 4 × CH3CO); 13C NMR (125 MHz, DMSO-d6): 
δ 177.8 (C=S), 169.9‒169.3 (4 × CH3CO), 166.6 (C-5ʹʹ), 
130.8 (CH=N), 101.5 (C-4ʹʹ), 81.2 (C-1ʹ), 72.5 (C-5ʹ), 72.3 
(C-3ʹ), 70.8 (C-2ʹ), 67.8 (C-4ʹ), 63.6 (C-1‴), 61.7 (C-6ʹ), 
30.6 (C-2‴), 30.0 (C-6‴), 24.5 (C-4‴), 24.1 (C-3‴), 24.0 
(C-5‴), 20.4‒20.3 (4 × CH3CO); ESI–MS (‒MS): m/z (%) 




The synthesized compounds 4a–o were screened in vitro 
for their antibacterial activities against bacteria namely 
Staphylococcus epidermidis (ATCC 12228) and Bacillus 
subtilis (ATCC 6633) as Gram positive bacteria, Escheri-
chia coli (ATCC 25922) and Salmonella enterica (ATCC 
15442) as Gram negative bacteria, were tested by using 
agar well diffusion (cup-plate) method [32]. The steri-
lized nutrient agar medium was distributed 100 mL each 
and allowed to cool to room temperature. The 24 h old 
Mueller–Hinton broth cultures of test bacteria were 
swabbed on sterile Mueller–Hinton agar plates in steri-
lized Petri dishes using sterile cotton swab followed 
by punching wells of 6 mm with the help of sterile cork 
borer. The standard drug (ciprofloxacin, 1 mg/mL of ster-
ile distilled water), compounds 4a–o (500 μg/mL in 10 % 
DMSO, prepared by dissolving 2.5  mg of substance in 
5 mL of 10 % DMSO solution in water), and control sam-
ple (a 10  % solution of DMSO in water) were added to 
the respectively labelled 6 mm diameter wells. The plates 
were allowed to stand for 30 min and then incubated at 
37 °C for 72 h in upright position. When growth inhibi-
tion zones were developed surrounding each cup, their 
diameter in mm was measured and compared with that 
of ciprofloxacin (Table 3).
The antibacterial activities against above bacteria 
of all the synthesized derivatives also were evaluated 
in  vitro by serial tube dilution method [33]. The com-
pounds and standard drug ciprofloxacin were dis-
solved in DMSO to give a concentration of 5  μg/mL 
(stock solution). A set of test tubes of capacity 5 mL was 
washed, cleaned and dried completely. Double strength 
nutrient broth was used as a growth/culture media 
for all bacteria. The culture media was made by dis-
solving 15  g of nutrient broth No. 2 in 1  L of distilled 
water. Approximately 1  mL of this culture media was 
prepared and transferred to each test tube by micro-
pipette and capped with non-adsorbent cotton plugs. 
A set of test tubes containing 1 mL culture media was 
sterilized in an autoclave at 15 psi pressure at 121 °C for 
20 min. Sub-culturing of bacteria was done by transfer-
ring a loopful of particular bacterial strain from stand-
ard bacterial agar slant to 10  mL sterilized nutrient 
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broth aseptically in a laminar air flow cabinet. It was 
then incubated for a period of 24 h at 37  °C in a incu-
bator. After 24 h incubation the bacterial stain suspen-
sion was prepared by aseptically inoculating 0.2  mL of 
revived bacterial colony into 100 mL of 0.9 % m/v saline. 
The study involved a series of five assay tubes for each 
compound against each strain. A stock solution of each 
test compound at concentration 5  μg/mL was serially 
diluted in series of 5 assay test tubes (containing 1 mL 
nutrient broth) to give concentration of 2.5, 1.25, 0.625, 
0.313 and 0.156 μg/mL. Then, 0.1 mL of normal saline 
suspension of revived bacteria was added to each test 
tube. The inoculated tubes were incubated at 37  °C for 
24 h. The MIC (minimum inhibitory concentration) val-
ues were determined by subsequently checking for the 
absence of visual turbidity (Table 4).
Experiments were repeated three times, and the results 
were expressed as average values.
Antifungal activity
The synthesized compounds 4a–o were screened for 
their antifungal activity against three fungal strains 
[34], namely Aspergillus niger 439, Candida albicans 
ATCC 7754, Fusarium oxysporum M42, at the concen-
tration levels of 500 μg/mL (Table 4) by agar well diffu-
sion (cup-plate) method, using nystatin as the standard 
and control sample is a 10 % solution of DMSO in water. 
The sterilized potato dextrose agar medium incubated at 
30 °C for 48 h, then the subculture of fungus were added, 
and shaken thoroughly to ensure uniform distribution. 
After that, this was poured into previously sterilized 
and labelled Petri dishes and allowed to solidify. Two 
cups were filled with 0.1 mL of two test dilutions and the 
other two cups with respective concentrations of stand-
ard dilutions. The plates were left as it is for 2–3  h for 
diffusion and then they were kept for 24 h at 37  °C for 
incubation. Then the diameter of the zones of growth 
inhibition was measured and compared with that of 
standard (nystatin).
Similarly, the antifungal activities against above fungi 
of all thiosemicarbazone derivatives also were evaluated 
in  vitro by serial tube dilution method [33, 34]. Experi-
ments were repeated three times, and the results were 
expressed as average values.
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